Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells

被引：61

作者：

Hong, Seung-Ho

Cho, Okki

Kim, Koyngmin

Shin, Ho-Joon

Kotenko, Sergei V.

Park, Sun

机构：

[1] Ajou Univ, Sch Med, Dept Microbiol, Suwon 442749, South Korea

[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA

来源：

VIRUS RESEARCH | 2007年 / 126卷 / 1-2期

关键词：

hepatitis B virus; interleukin; 29; proteins; virus replication; receptors; interferon;

D O I：

10.1016/j.virusres.2007.03.006

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The antiviral activity of interferon-lambda (IFN-lambda) against several viruses has been reported, but it has not been investigated whether human IFN-lambda can affect replication of the hepatitis B virus (HBV) in human hepatocyte-derived cells. We found that replication of HBV in a human hepatoma cell line was reduced by approximately 30% following treatment with a high concentration of IFN-lambda. Furthermore, we showed that replication of HBV in another human hepatoma cell line was not suppressed by IFN-lambda. However, these cell lines showed a similar level of transcription for the heterodimeric IFN-lambda receptor and the IFN-lambda-induced antiviral proteins. Our results suggest that the antiviral activity of IFN-lambda against HBV may be limited in human cells. (C) 2007 Elsevier B.V. All rights reserved.

引用

收藏

页码：245 / 249

页数：5

相关论文

共 18 条

[1] IFN-λ:: Novel antiviral cytokines [J].

Ank, Nina ;

West, Hans ;

Paludan, Soren R. .

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2006, 26 (06) :373-379

[2] IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression [J].

Brand, S ;

Beigel, F ;

Olszak, T ;

Zitzmann, K ;

Eichhorst, ST ;

Otte, JM ;

Diebold, J ;

Diepolder, H ;

Adler, B ;

Auernhammer, CJ ;

Göke, B ;

Dambacher, J .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 289 (05) :G960-G968

[3] SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29 [J].

Brand, S ;

Zitzmann, K ;

Dambacher, J ;

Beigel, F ;

Olszak, T ;

Vlotides, G ;

Eichhorst, ST ;

Göke, B ;

Diepolder, H ;

Auernhammer, CJ .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (02) :543-548

[4] Real-time PCR for detection and quantitation of hepatitis B virus DNA [J].

Chen, RW ;

Piiparinen, H ;

Seppänen, M ;

Koskela, P ;

Sarna, S ;

Lappalainen, M .

JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) :250-256

[5] Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus [J].

Chi, Bo ;

Dickensheets, Harold L. ;

Spann, Kirsten M. ;

Alston, Marc A. ;

Luongo, Cindy ;

Dumoutier, Laure ;

Huang, Jiaying ;

Renauld, Jean-Christophe ;

Kotenko, Sergei V. ;

Roederer, Mario ;

Beeler, Judy A. ;

Donnelly, Raymond P. ;

Collins, Peter L. ;

Rabin, Ronald L. .

JOURNAL OF VIROLOGY, 2006, 80 (10) :5032-5040

[6] Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3 [J].

Dumoutier, L ;

Lejeune, D ;

Hor, S ;

Fickenscher, H ;

Renauld, JC .

BIOCHEMICAL JOURNAL, 2003, 370 :391-396

[7] Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins [J].

Fernández, M ;

Ouiroga, JA ;

Carreño, V .

JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2073-2082

[8] Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus [J].

Fu, L ;

Cheng, YC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3402-3407

[9] Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein [J].

Gordien, E ;

Rosmorduc, O ;

Peltekian, C ;

Garreau, F ;

Bréchot, C ;

Kremsdorf, D .

JOURNAL OF VIROLOGY, 2001, 75 (06) :2684-2691

[10] Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy [J].

Imanaka, K ;

Tamura, S ;

Fukui, K ;

Ito, N ;

Kiso, S ;

Imai, Y ;

Naka, T ;

Kishimoto, T ;

Kawata, S ;

Shinomura, Y .

JOURNAL OF VIRAL HEPATITIS, 2005, 12 (02) :130-138